Comparison of efficacy of Haridrakahanda and Vyoshadi vati in the treatment of Allergic Rhinitis as prophyalctic medicine

Comparative Clinical trial of efficacy of Haridrakahanda and Vyoshadi vati in the management of Allergic Rhinitis as prophyalctic medicine

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/06/019823

Enrollment

Registered

2019-06-24

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Haridrakhanada: Haridrakhanda prepared by awaleha kalpana.given to patienta of age between 18 to 60 dose 5gm twice a day for 30 days n follow up will taken on 15th,30th,60th and 90th da

Eligibility

Inclusion criteria

Inclusion criteria: Patient diagnosed as alleegic rhinitis

Exclusion criteria

Exclusion criteria: Patients with vasomotor rhinitis, acute infective rhinitis, atrophic rhinitis, pregnant women, lactating mother, patients suffering from malignancy, tuberculosis, systemic illness

Design outcomes

Primary

Measure	Time frame
To study the efficacy of Haridrakahanda and Vyoshadi vati in the management of Allergic Rhinitis as prophyalctic medicineTimepoint: 3 months	—

Secondary

Measure	Time frame
To study efficacy of Haridrakahanda in management of allergic rhinitis as prophylactic medicine To study the efficacy of vyoshadi vati in management of allergic rhinitis as prophylactic medicine To study adverse effects of Haridrakhanada and Vyoshadi vatiTimepoint: 3 months	—

Countries

India

Contacts

Public ContactDr Akshata Rajaram Kalje

Tilak Ayurved Mahavidyalaya

salvisangeeta@yahoo.co.in9822082795

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026